Key molecular mechanisms, including lipid metabolism dysregulation, insulin resistance and mitochondrial dysfunction, are examined with a focus on understanding the basis for progression to metabolic dysfunction‐associated steatohepatitis (MASH). This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.